GSK vs LEGH · P/E 13, $103.31B cap vs P/E 10, rev $66.3M
GlaxoSmithKline PLC ADR (GSK) versus Legacy Housing Corp (LEGH) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Legacy Housing Corp (LEGH) is a residential construction company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LEGH revenue for 2026-06-30 was $66.3M. Net income was $23.5M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. LEGH currently screens at market cap $578.1M and trailing P/E 10.5.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LEGH currently screens at market cap $578.1M and trailing P/E 10.5.
Not investment advice. Open the GSK and LEGH stock pages for the full models.
Not investment advice.